No Long-Term Advantage Seen for Off-Pump Versus On-Pump CABG

THURSDAY, March 10, 2022 (HealthDay News) -- Coronary artery bypass grafting (CABG) outcomes are similar at 10 years for veterans undergoing "on-pump" or "off-pump" procedures, according to a study published online Feb. 16 in JAMA Surgery.
Jacquelyn A. Quin, M.D., from the Veterans Affairs Boston Healthcare System in West Roxbury, Massachusetts, and colleagues evaluated the 10-year outcomes and costs of off-pump versus on-pump CABG. The analysis included 2,203 veterans randomly assigned to the off-pump group (1,104 patients) or the on-pump group (1,099 patients).
The researchers found that the 10-year death rates were 34.2 percent for the off-pump group and 31.1 percent for the on-pump group (relative risk, 1.05; 95 percent confidence interval, 0.99 to 1.11; P = 0.12). For the off-pump group, the median time to the composite end point (all-cause death or repeated revascularization) was 4.6 years, which was approximately 4.3 months shorter than that for the on-pump group (5.0 years). There were no significant 10-year treatment-related differences for any other primary or secondary end points.
"For veterans, in the absence of contraindications, the traditional on-pump CABG technique should not be supplanted by an off-pump CABG approach," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Related Posts
AHA News: Para muchos hispanos, las inquietudes relacionadas con la vacunación son una cuestión de confianza
MIÉRCOLES, 15 de septiembre de 2021 (American Heart Association News) -- Desde...
Peripheral Endovascular Intervention Incidence Increased Among Blacks
WEDNESDAY, Aug. 10, 2022 (HealthDay News) -- Black adults have higher...
Los trasplantes fecales podrían transmitir la viruela del simio, según la FDA
MIÉRCOLES, 24 de agosto de 2022 (HealthDay News) -- Los tratamientos de...
ASCO: Minimally Invasive Noninferior to Open Surgery for Pancreatic Cancer
THURSDAY, June 1, 2023 (HealthDay News) -- For patients with resectable...